Clinical trials
5 active studies led by PharmaMar, of 52 in all
Source: ClinicalTrials.gov, Studies with PharmaMar (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
- 0Reports naming them
- 1Markets in public records
- 0Regions & countries
- 5Active trials they lead[1]
[1] ClinicalTrials.gov, Studies led by PharmaMar or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public data on PharmaMar
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
Company facts
- Website
- pharmamar.com
- Home country
- Spain
- Legal name
- PHARMA MAR, S.A.
- Type
- Medicines
See them on ClinicalTrials.gov (opens in a new tab)
Trials over time
Studies PharmaMar leads, by the year they started and their phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- No phase (devices, observational)
Source: ClinicalTrials.gov, Studies with PharmaMar or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets where public records show them
Markets we cover where free public records show PharmaMar: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
Topics
The topics of the markets PharmaMar is in.
From our blog
Stories on the topics PharmaMar works in.
Molecular Point-of-Care Tests: Lab Accuracy, Clinic Speed
TB killed 1.23 million people in 2024. WHO now recommends rapid molecular tests first, bringing lab-grade…
Read
Antimicrobial Resistance: Why Faster Testing Matters
Drug-resistant infections already kill over a million people a year. Faster testing helps doctors pick the…
Read
Needleless Connectors: Small Device, Big Infection Impact
Needleless connectors protect staff from needle injuries, but if not cleaned they can let germs into the…
Read